A patient with Parkinson's disease suffering from depression was successfully treated with bupropion;Een depressieve patiente met de ziekte van Parkinson succesvol behandeld met bupropion

Nederlands Tijdschrift voor Geneeskunde

Volumn 144, Issue 45, 2000, Pages 2157-2159

  Leentjens, A F G ^a   Verhey, F R J ^a   Vreeling, F W ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; DOPAMINE; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN; SEROTONIN UPTAKE INHIBITOR; ANTIDEPRESSANT AGENT; DOPAMINE UPTAKE INHIBITOR;

AGED; ARTICLE; CASE REPORT; DEPRESSION; DOPAMINE UPTAKE; DRUG EFFICACY; FEMALE; HUMAN; NORADRENERGIC SYSTEM; PARKINSON DISEASE; TREATMENT OUTCOME;

AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; DEPRESSION; DOPAMINE UPTAKE INHIBITORS; FEMALE; HUMANS; PARKINSON DISEASE; TREATMENT OUTCOME;

EID: 0034605620     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Depression and Parkinson's disease: A review
2. Selective scrotonin-reuptake inhibitor-induced movement disorders
3. Depression: Impact and management by the patient and family
4. Depression in Parkinson's disease: Impediments to recognition and treatment options
5. Treatment of depression in Parkinson's disease: A mete-analysis
6. Cognitieve bijwerkingen van lithium; een mete-analyse en aanbevelingen
7. A rating scale for depression
8. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician
9. Unified Parkinson's disease rating scale
10. Electroconvulsietherapie (ECT) als behandelmogelijkheid voor motorische symptomen van M. Parkinson
11. Het effect van medicamenteuze vervolgbehandeling na succesvolle elektroconvulsietherapie voor therapieresistente depressie is nog teleurstellend
12. The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease
13. Mechanisms of action and clinical characteristics of three atypical antidepressants: Venlafaxine, nefazodone, bupropion
14. Present status of drug therapy of depression in late life
15. Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline
16. Bupropion in Parkinson's disease
17. Bupropion-induced psychosis
18. Falling backward in two elderly patients taking bupropion
19. Depression and the dynamics of smoking. A national perspective
20. A comparison of sustained-release bupropion and placebo for smoking cessation